ask="N/A"
ask_size="N/A"
average_daily_volume="98674"
bid="N/A"
bid_size="N/A"
book_value="0.6940"
change="N/A"
change_from_200_day_moving_average="-0.2516"
change_from_50_day_moving_average="0.0111"
change_from_52_week_high="-6.7299"
change_From_52_week_low="0.2999"
change_in_percent="N/A"
close="1.2201"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.1560"
ebitda="-17.60M"
eps_estimate_current_year="-1.0900"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="-0.8200"
ex_dividend_date="N/A"
float_shares="6119000"
high="N/A"
high_52_weeks="7.9500"
last_trade_date="2/13/2017"
last_trade_price="1.2201"
last_trade_size="N/A"
last_trade_time="3:56pm"
low="N/A"
low_52_weeks="0.9202"
market_capitalization="20.00M"
moving_average_200_day="1.4717"
moving_average_50_day="1.2090"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.0000"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-17.0953%"
percent_change_from_50_day_moving_average="+0.9156%"
percent_change_from_52_week_high="-84.6528%"
percent_change_from_52_week_low="+32.5907%"
previous_close="1.2201"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.7581"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.5900"
stock_exchange="NGM"
symbol="ORPN"
volume="0"
weeks_range_52="0.9202 - 7.9500"
